Revised forecast
Fiscal year ending June 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Impairment loss ¥24.898 million; loss on disposal of fixed assets ¥8.000 million; total extraordinary losses ¥32.898 million
| Item | Details |
|---|---|
| Net Sales | Not disclosed → 13,800 Millions of yen |
| Operating profit | Not disclosed → 420 Millions of yen |
| Ordinary income | Not disclosed → 300 Millions of yen |
| Profit attributable to owners of the parent | Not disclosed → 200 Millions of yen |
| Net income per share | Not disclosed → 51.88 yen and sen |
| Fiscal Period Covered | Fiscal year ending June 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales ¥11,804 million; operating loss ¥521 million; ordinary loss ¥639 million; net loss attributable to owners of the parent ¥711 million; net loss per share ¥184.53 |
| Details and amount of extraordinary loss | Impairment loss ¥24.898 million; loss on disposal of fixed assets ¥8.000 million; total extraordinary losses ¥32.898 million |
| Dividend forecast revision | The company forecasts an annual dividend of ¥18 for the fiscal year ending June 2027, comprising an interim dividend of ¥9 and a year-end dividend of ¥9. There is no indication that this is a revision. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the real estate business, condominium handover results fell significantly short of plan because of the influx of competitors, persistently high construction costs and weaker consumer sentiment resulting from higher mortgage interest rates. In the medical services business, the company recorded an allowance for doubtful accounts because of delays in improving the management of a medical corporation. In the RV business, sales volumes also fell below plan. For the fiscal year ending June 2027, the company plans to strengthen its sourcing structure for real estate and business-use land, diversify its real estate products and invest in human resources.